Myeloproliferative Neoplasms News

ASH will present awards to former Vice President Joe Biden, as well as journalist and author Tom Brokaw, in recognition of their advocacy for biomedical research and hematology.

ASH announced the recipients of the society’s 2018 Scholar Awards.

The CDC has released a public-use research database that combines data from CDC’s National Program of Cancer Registries and NCI’s SEER program.

Chronic neutrophilic leukemia is a rare disease, affecting an estimated 200 individuals aged 65 and older across the world.

The Leukemia & Lymphoma Society committed $46 million toward research efforts at medical institutions worldwide.

One-fifth of patients with cancer experienced PTSD within several months of diagnosis, according to results of a prospective study published in Cancer.

WASHINGTON — When diagnosed with Hodgkin lymphoma at the age of 33 years, FDA Commissioner Scott Gottlieb, MD, was told he had a 90% chance of survival.

The FDA today authorized Integrated Mutation Profiling of Actionable Cancer Targets, or IMPACT, an in vitro diagnostic test that uses next-generation sequencing to rapidly identify the presence of mutations in 468 genes.

The FDA today approved letermovir tablets and injection, the first treatment indicated for cytomegalovirus prophylaxis in adults who have been exposed to cytomegalovirus and underwent an allogeneic hematopoietic stem cell transplant.

Alcohol use — whether light, moderate or heavy — increases cancer risk, and public health measures are needed to reduce high-risk alcohol consumption, according to an ASCO statement.